US Dollar vs Yen

登録してリアルタイムのチャート、分析ツール、価格を入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Senti Biosciences Inc (SNTI)
Senti Biosciences Inc (SNTI) ニュース

SNTI

Senti Biosciences (SNTI)

Senti Biosciences Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:SNTI

1 2 3 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/30	05 : 14	Edgar (US Regulatory)	Form ARS - Annual Report to Security Holders	NASDAQ:SNTI	Senti Biosciences Inc
2024/05/30	05 : 09	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:SNTI	Senti Biosciences Inc
2024/05/30	05 : 07	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:SNTI	Senti Biosciences Inc
2024/05/18	06 : 19	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:SNTI	Senti Biosciences Inc
2024/05/18	06 : 17	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SNTI	Senti Biosciences Inc
2024/05/13	21 : 15	GlobeNewswire Inc.	Senti Bio Announces First Patient Dosed in Phase 1 Clinical Trial of SENTI-202 for the Treatment of Relapsed or Refractory Hematologic Malignancies Including Acute Myeloid Leukemia	NASDAQ:SNTI	Senti Biosciences Inc
2024/05/10	05 : 15	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:SNTI	Senti Biosciences Inc
2024/05/10	05 : 05	GlobeNewswire Inc.	Senti Bio Announces First Quarter 2024 Results and Reviews Recent Corporate Highlights	NASDAQ:SNTI	Senti Biosciences Inc
2024/04/30	21 : 05	GlobeNewswire Inc.	Senti Bio Announces Publication of SENTI-202 Preclinical Data Demonstrating Potential of Logic-Gated CAR-NK Cell Therapy for the Treatment of Acute Myeloid Leukemia (AML)	NASDAQ:SNTI	Senti Biosciences Inc
2024/03/22	05 : 05	GlobeNewswire Inc.	Senti Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Reviews Recent Highlights	NASDAQ:SNTI	Senti Biosciences Inc
2024/01/06	06 : 05	GlobeNewswire Inc.	Senti Bio Announces Strategic Steps to Prioritize Investment in Lead Clinical Program	NASDAQ:SNTI	Senti Biosciences Inc
2023/12/22	20 : 30	GlobeNewswire Inc.	Senti Bio Announces FDA Clearance of IND Application for SENTI-202 for the Treatment of Relapsed or Refractory Hematologic Malignancies Including Acute Myeloid Leukemia	NASDAQ:SNTI	Senti Biosciences Inc
2023/11/14	06 : 15	GlobeNewswire Inc.	Senti Bio Announces Third Quarter 2023 Results and Pipeline Updates	NASDAQ:SNTI	Senti Biosciences Inc
2023/11/07	06 : 05	GlobeNewswire Inc.	Senti Bio Announces New Strategic Collaboration with Celest Therapeutics for Clinical Development of SENTI-301A in China	NASDAQ:SNTI	Senti Biosciences Inc
2023/10/31	22 : 06	GlobeNewswire Inc.	Senti Bio Announces Multiple Data Presentations at the Society for Immunotherapy of Cancer Annual Meeting	NASDAQ:SNTI	Senti Biosciences Inc
2023/09/27	22 : 05	GlobeNewswire Inc.	Senti Bio Announces Multiple Data Presentations at the Society for Immunotherapy of Cancer 2023 Meeting	NASDAQ:SNTI	Senti Biosciences Inc
2023/09/27	05 : 05	GlobeNewswire Inc.	Senti Bio to Participate in Upcoming Conferences	NASDAQ:SNTI	Senti Biosciences Inc
2023/09/05	21 : 30	GlobeNewswire Inc.	Senti Bio to Participate in Upcoming Investor Conferences	NASDAQ:SNTI	Senti Biosciences Inc
2023/08/11	21 : 35	GlobeNewswire Inc.	Senti Bio Announces Second Quarter 2023 Results and Pipeline Updates	NASDAQ:SNTI	Senti Biosciences Inc
2023/08/10	21 : 35	GlobeNewswire Inc.	Senti Bio Announces Closing of Transaction Leveraging its CMC Capabilities into a Cell and Gene Therapy Manufacturing Innovation Business Backed by Celadon Partners	NASDAQ:SNTI	Senti Biosciences Inc
2023/05/20	21 : 05	GlobeNewswire Inc.	Senti Bio Highlights Initial Gene Circuit Data From Collaborations at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting	NASDAQ:SNTI	Senti Biosciences Inc
2023/05/10	05 : 05	GlobeNewswire Inc.	Senti Bio Announces First Quarter 2023 Results and Pipeline Updates	NASDAQ:SNTI	Senti Biosciences Inc
2023/05/03	05 : 45	GlobeNewswire Inc.	Senti Bio Announces Multiple Data Presentations at the American Society of Gene and Cell Therapy 2023 Annual Meeting	NASDAQ:SNTI	Senti Biosciences Inc
2023/04/17	21 : 45	GlobeNewswire Inc.	Senti Bio Highlights Preclinical Data from Multiple Gene Circuit Enabled Cell Therapy Programs at Annual AACR Meeting	NASDAQ:SNTI	Senti Biosciences Inc
2023/04/14	22 : 00	GlobeNewswire Inc.	Senti Bio to Participate in Upcoming Investor Conferences	NASDAQ:SNTI	Senti Biosciences Inc
2023/03/23	06 : 09	GlobeNewswire Inc.	Senti Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Reviews Recent Highlights	NASDAQ:SNTI	Senti Biosciences Inc
2023/03/15	05 : 35	GlobeNewswire Inc.	Senti Bio Announces Three Preclinical Data Presentations from Gene Circuit-Enhanced CAR-NK Cell Oncology Pipeline at Annual AACR Meeting	NASDAQ:SNTI	Senti Biosciences Inc
2023/02/04	06 : 05	GlobeNewswire Inc.	Senti Biosciences Announces New Employment Inducement Grants	NASDAQ:SNTI	Senti Biosciences Inc
2023/02/02	06 : 05	GlobeNewswire Inc.	Senti Bio to Present at the SVB Securities Global Biopharma Conference	NASDAQ:SNTI	Senti Biosciences Inc
2023/01/27	22 : 00	GlobeNewswire Inc.	Senti Bio Announces Pipeline Prioritization to Focus on Logic Gated Cell Therapies; Updates Cash Runway Guidance	NASDAQ:SNTI	Senti Biosciences Inc

Showing the most relevant articles for your search:NASDAQ:SNTI

1 2 3 次へ >>

US Dollar vs Euro

Financial Select Sector

Gold vs US Dollar

Invesco QQQ Trust Series 1

JP Morgan Chase

Verizon Communications

Health Care Select Sector

Energy Select Sector SPDR

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約